Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals

References

• Bauwens J, de Lusignan S, Sherlock J, Ferreira F, Künzli N, Bonhoeffer J. Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule. Vaccine. 2021;9:100115. doi:10.1016/j.jvacx.2021.100115.
   Web of Science ®Google Scholar
• Bonanni P, Steffen R, Schelling J, Balaisyte-Jazone L, Posiuniene I, Zatoński M, Van Damme P. Vaccine co-administration in adults: an effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023;19(1):2195786. doi:10.1080/21645515.2023.2195786.
   PubMed Web of Science ®Google Scholar
• Durando P, Esposito S, Bona G, Cuccia M, Desole MG, Ferrera G, Gabutti G, Pellegrino A, Salvini F, Henry O, et al. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: a phase IIIb, randomized, multi-center study in Italy. Vaccine. 2016;34(36):4278–6. doi:10.1016/j.vaccine.2016.07.009.
   PubMed Web of Science ®Google Scholar
• Sinopoli MT, Belfiori G, Fusillo T. Le co-somministrazioni come strumento per raggiungere e mantenere le coperture vaccinali previste dal pnpv nel primo anno di vita. In: Atti 54° Congresso Nazionale SITI 2021; Lecce, Italy; 2021.
   Google Scholar
• Turner N, Grant C, Goodyear-Smith F, Petousis-Harris H. Seize the moments: missed opportunities to immunize at the family practice level. Family Practice. 2009;26(4):275–8. doi:10.1093/fampra/cmp028.
   PubMed Web of Science ®Google Scholar
• Boeddha NP, Schlapbach LJ, Driessen GJ, Herberg JA, Rivero-Calle I, Cebey-López M, Klobassa DS, Philipsen R, de Groot R, Inwald DP, et al. Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Crit Care. 2018;22(1):143. doi:10.1186/s13054-018-2052-7.
   PubMedGoogle Scholar
• Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety, and future directions. Paediatr Drugs. 2018;20(3):223–33. doi:10.1007/s40272-018-0283-3.
   PubMed Web of Science ®Google Scholar
• Azzari C, Moriondo M, Nieddu F, Guarnieri V, Lodi L, Canessa C, Indolfi G, Giovannini M, Napoletano G, Russo F, et al. Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014–2018). Vaccines. 2020;8(3):8. doi:10.3390/vaccines8030469.
   Web of Science ®Google Scholar
• Bonanni P, Conforti G, Franco E, Gabutti G, Marchetti F, Matte A, Prato R, Vitali Rosati G, Vitale F Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy. Hum Vaccin Immunother. 2021;17:4636–45 doi:10.1080/21645515.2021.1955611.
   PubMed Web of Science ®Google Scholar
• Lodi L, Barbati F, Amicizia D, Baldo V, Barbui AM, Bondi A, Costantino C, Da Dalt L, Ferrara L, Fortunato F, et al. Four-component recombinant protein–based vaccine effectiveness against serogroup B meningococcal disease in Italy. JAMA Netw Open. 2023;6(8):e2329678. doi:10.1001/jamanetworkopen.2023.29678.
   PubMed Web of Science ®Google Scholar
• Azzari C, Canessa C, Lippi F, Moriondo M, Indolfi G, Nieddu F, Martini M, de Martino M, Castiglia P, Baldo V, et al. Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing. Vaccine. 2014;32(10):1187–91. doi:10.1016/j.vaccine.2013.09.055.
   PubMed Web of Science ®Google Scholar
• Vaccinazioni dell’età pediatrica. Anno 2021 (coorte 2019). Coperture vaccinali a 24 mesi (per 100 abitanti). [accessed 2023 Apr 13]. https://www.salute.gov.it/imgs/C_17_tavole_20_10_0_file.pdf.
   Google Scholar
• Bauwens J, Saenz LH, Reusser A, Künzli N, Bonhoeffer J. Safety of Co-administration versus separate administration of the same vaccines in children: a systematic literature review. Vaccines. 2019;8(1):12. doi:10.3390/vaccines8010012.
   Web of Science ®Google Scholar
• Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2023–2025. [accessed 2023 Sep]. https://www.trovanorme.salute.gov.it/norme/dettaglioAtto.spring?id=95963&page=newsett.
   Google Scholar
• Giuffrida S, Seta G, Gurnari A, Fiasca F, Marchetti F. Insights and expectations of healthcare professionals on the implementation of the updated pediatric regional immunization calendar in Calabria, Italy. Hum Vaccin Immunother. 2023;19(3):2275475. doi:10.1080/21645515.2023.2275475.
   PubMed Web of Science ®Google Scholar
• Barbato M, Rosselli R, Russo C, Butera A, Esposito L, Fiasca F, Cavallo M Results of the first national survey on vaccines co-administration knowledge and beliefs carried out among Italian health assistants. Popul Med. 2023;5(Supplement). doi:10.18332/popmed/165298.
   Google Scholar
• Wagner A, Kundi M, Zwiauer K, Wiedermann U. Paediatricians require more information before they routinely co-administer the meningococcal B vaccine with routine infant vaccines. Acta Paediatrica. 2015;104(10):439–47. doi:10.1111/apa.13100.
   Web of Science ®Google Scholar
• Liu B, Cao B, Wang C, Han B, Sun T, Miao Y, Lu Q, Cui F. Immunogenicity and safety of childhood combination vaccines: a systematic review and meta-analysis. Vaccines. 2022;10(3):10. doi:10.3390/vaccines10030472.
   Web of Science ®Google Scholar
• Bauwens J, de Lusignan S, Weldesselassie YG, Sherlock J, Künzli N, Bonhoeffer J. Safety of routine childhood vaccine coadministration versus separate vaccination. BMJ Glob Health. 2022;7(9):e008215. doi:10.1136/bmjgh-2021-008215.
   PubMed Web of Science ®Google Scholar
• Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health. 2018;2(6):395–403. doi:10.1016/S2352-4642(18)30103-2.
   PubMedGoogle Scholar
• European Medicines Agency. Bexsero summary of product characteristics. [accessed 2024 Feb]. https://www.ema.europa.eu/en/documents/product-information/bexsero-epar-product-information_en.pdf.
   Google Scholar
• Zafack JG, Bureau A, Skowronski DM, De Serres G. Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials. BMJ Open. 2019;9(5):e026953. doi:10.1136/bmjopen-2018-026953.
   PubMed Web of Science ®Google Scholar
• Abitbol V, Sohn W-Y, Horn M, Safadi, MAP. Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: a literature review. Hum Vaccines Immunother. 2023;19:2245705. doi:10.1080/21645515.2023.2245705.
   PubMed Web of Science ®Google Scholar
• O’Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014;74(1):15–30. doi:10.1007/s40265-013-0155-7.
   PubMed Web of Science ®Google Scholar
• Gossger N, Snape MD, Yu L-M, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA. 2012;307(6):573–582. doi:10.1001/jama.2012.85.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet. 2013;381(9869):825–35. doi:10.1016/S0140-6736(12)61961-8.
   PubMed Web of Science ®Google Scholar
• Martinelli D, Fortunato F, Marchetti F, Prato R. Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence. Hum Vaccin Immunother. 2021;17(5):1546–51. doi:10.1080/21645515.2020.1816109.
   PubMed Web of Science ®Google Scholar
• UK Health Security Agency. The complete routine immunisation schedule from February 2022. [accessed 2023 July]. https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule/the-complete-routine-immunisation-schedule-from-february-2022.
   Google Scholar
• Rajan M, Marchevsky N, Sinclair G, O’Brien K, Jefferies K, Owino N, Hallis B, Goldblatt D, Matheson M, Cuthbertson H, et al. A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group B meningococcal vaccine. Pediatr Infect Dis J. 2023;42(1):66–73. doi:10.1097/INF.0000000000003753.
   PubMed Web of Science ®Google Scholar
• UK Health Security Agency. Using paracetamol to prevent and treat fever after MenB vaccination. [accessed 2023 Sep]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1110220/UKHSA-paracetamol-MenB-2022.pdf.
   Google Scholar
• European Centre for Disease Prevention and Control. E-CDC Scheduler. [accessed 2024 Feb]. https://vaccine-schedule.ecdc.europa.eu/.
   Google Scholar
• Junta of Castile and León. Calendario Vacunal Para Toda La Vida. [accessed 2024 Feb]. https://www.saludcastillayleon.es/profesionales/es/vacunaciones/calendario-vacunal-toda-vida-castilla-leon-2023.ficheros/2428566-calendario%20vacunal%20def%20%2850x70%29.pdf.
   Google Scholar
• De Galicia X. Calendario De Inmunización A Lo Largo De Toda La Vida. [accessed 2024 Feb]. https://www.sergas.es/Saude-publica/Documents/7247/INS_CALENDARIO_INMUNIZACION_13-11-2023%20(ES).pdf.
   Google Scholar
• Pellegrino A, Busellu G, Cucchi A, Cavallaro A, Gabutti G. Vaccine co-administration in paediatric age: the experience of the local health unit of cuneo-1 (Ambito di cuneo), Italy. Acta Biomed. 2010;81:204–9.
   PubMedGoogle Scholar
• Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2017–2019. [accessed 2024 Feb]. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
   Google Scholar
• Regione Calabria. Calendario Vaccinale Regione Calabria. 2022. [accessed 2023 Feb]. https://www.regione.calabria.it/website/portalmedia/decreti/2022-04/All.-DCA-32-del-7.4.2022-_Calendario-Vaccinale-Regionale.pdf.
   Google Scholar
• Centers for Disease Prevention and Control. CDC pink book General rules for immunization. [accessed 2024 Feb]. https://www.cdc.gov/vaccines/pubs/pinkbook/genrec.html.
   Google Scholar
• World Health Organization. WHO recommendations for routine immunization – summary tables. [accessed 2024 Aug]. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization---summary-tables.
   Google Scholar
• Poscia A, Lo Giudice M, Nigri L, Perone V, Russo R, Bresesti I, Agosti M. Italian immunization calendar implementation: Time to optimize number of vaccination appointments? Hum Vaccin Immunother. 2023;19(1):2156745. doi:10.1080/21645515.2022.2156745.
   PubMed Web of Science ®Google Scholar
• Giuffrida SC. L’esperienza della Regione Calabria sul calendario vaccinale. CME Webinar – 15 April 2023 – The Healthcare Assistant and Vaccinations In a Context Of Continuous Change. 2023 [accessed 2024 Feb]. https://www.vaccinarsintoscana.org/eventi/2023/15.04.2023-webinar-ecm-l%E2%80%99assistente-sanitario-e-le-vaccinazioni-in-un-contesto-di-cambiamento-continuo.
   Google Scholar
• Bonanni P, Boccalini S, Bechini A, Varone O, Matteo G, Sandri F, Gabutti G. Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. Hum Vaccin Immunother. 2020;16(6):1313–21. doi:10.1080/21645515.2019.1688032.
   PubMed Web of Science ®Google Scholar
• Robert Koch Institut. Epidemiologisches Bulletin 4 2024. [accessed 2024 Feb]. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/04_24.pdf?__blob=publicationFile.
   Google Scholar